Showing results (31-40 of 80) with videos related to
Sort By:
Pageof 8
Breast Cancer Research and Treatment|July 17, 2013
Tumour diploidy and survival in breast cancer patients with BRCA2 mutationsLaufey Tryggvadottir, Elinborg J Olafsdottir, Gudridur H Olafsdottir, et al.Cancer Medicine|October 25, 2013
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancerInga Reynisdottir, Adalgeir Arason, Berglind O Einarsdottir, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcomeJohan Staaf, Markus Ringnér, Johan Vallon-Christersson, et al.Blood Cancer Journal|December 18, 2024
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening studyJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.British Journal of Cancer|August 19, 2016
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriersJon G Jonasson, Olafur A Stefansson, Oskar T Johannsson, et al.Breast Cancer Research : BCR|July 20, 2010
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 familiesAdalgeir Arason, Haukur Gunnarsson, Gudrun Johannesdottir, et al.Hemasphere|November 20, 2024
Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening studySæmundur Rögnvaldsson, Jón Þ Óskarsson, Sigrun Thorsteinsdóttir, et al.Breast Cancer Research : BCR|June 26, 2010
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsGöran Jönsson, Johan Staaf, Johan Vallon-Christersson, et al.Haematologica|July 13, 2023
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM studyAðalbjörg Ýr Sigurbergsdóttir, Sæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, et al.Leukemia|September 12, 2025
Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM studyLærke Sloth Andersen, Ricardo Berenguer Navarro, Sara Ekberg, et al.Pageof 8